References
- Richelson E., Nelson A. Antagonists by antidepressants of neurotransmitter receptors of normal human brain in vitro. J. Pharmacol. Exp. Ther. 1948; 230: 94–102
- Peroutka S. J. Pharmacological differentiation and characterization of 5HT1A 5HT1B and 5HT1C binding sites in rat frontal cortex. J. Neurochem. 1986; 47: 529–540
- Bolden C., Cusack B., Richelson E. Antagonism by antimuscarinic and neuroleptic compounds at the five cloned human muscarinic cholinergic receptors expressed in Chinese hamster ovary cells. J. Pharmacol. Exp. Ther. 1992; 260: 576–580
- Lowry H., Rosebrough N. J., Farr A. L., Randall R. J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951; 193: 265–273
- Wander T. J., Nelson A., Okazaki H., Richelson E. Antagonism of neuroleptics of serotonin 5-HT1A and 5-HT2A receptors of normal human brain in vitro. Eur. J. Pharmacol. 1987; 143: 279–282
- Gozlan H., El Mestikawy S., Pichat L., Glowinski J., Hamon M. Identification of presynaptic serotonin autoreceptors using a new ligand: [3H]-PAT. Nature 1983; 305: 140–142
- Munson P. J., Rodbard D. LIGAND: A versatile computerized approach for characterization of ligand-binding systems. Analyt. Biochem. 1980; 107: 220–239
- Fleming W. W., Westfall D. P., De La Landi L. S., Jellet L. B. Log-normal distribution of equieffective doses of norepinephrine and acetylcholine in several tissues. J. Pharmacol. Exp. Ther. 1972; 181: 339–345
- De Lean A., Hancock A. A., Lefkowitz R. J. Validation and statistical analysis of a computer modeling method for quantitative analysis of radio-ligand binding data for mixtures of pharmacological receptor subtypes. Mol. Pharmacol. 1992; 21: 5–16
- Cusack B., Stanton T., Bolden C., Richelson E. Antagonism by antidepressants and antihistaminics at the 5 cloned human muscarinic cholinergic receptors expressed in CHO-K1 cells. FASEB Abstracts 1992; 6: A1880